Ovid Therapeutics
OVID
OVID
50 hedge funds and large institutions have $21.7M invested in Ovid Therapeutics in 2019 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 23 increasing their positions, 8 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
4.03% more ownership
Funds ownership: 27.73% → 31.77% (+4%)
Holders
50
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$5.83M | |
| 2 | +$740K | |
| 3 | +$641K | |
| 4 |
Renaissance Technologies
New York
|
+$545K |
| 5 |
Wells Fargo
San Francisco,
California
|
+$544K |
Top Sellers
| 1 | -$1.32M | |
| 2 | -$191K | |
| 3 | -$71.4K | |
| 4 |
Millennium Management
New York
|
-$54K |
| 5 |
SG Americas Securities
New York
|
-$46K |